BRAF and central nervous system neoplasm: The authors also demonstrated that chloroquine could improve vemurafenib sensitivity in children with ganglioglioma, indicating that pediatric CNS tumors with BRAF (V600E) are autophagy-dependent and should be targeted with autophagy inhibition in combination with other therapeutic strategies.